CAUSEY CHRISTOPHER 4
4 · UNITED THERAPEUTICS Corp · Filed Mar 5, 2026
Insider Transaction Report
Form 4
CAUSEY CHRISTOPHER
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-03-04$119.76/sh+20$2,395→ 4,210 total - Sale
Common Stock
[F1][F2]2026-03-04$490.17/sh−20$9,803→ 4,190 total - Exercise/Conversion
Stock Option
[F1]2026-03-04−20→ 6,300 totalExercise: $119.76From: 2021-06-26Exp: 2030-06-26→ Common Stock (20 underlying)
Footnotes (2)
- [F1]This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $490.12 to $490.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Signature
/s/ John S. Hess, Jr. under Power of Attorney|2026-03-05